digital currency quotes, Featured

 Noon announcement: Huatong convertible bonds will soon stop converting shares; Platinum New Materials Thailand Base has obtained the project record. ① Huatong shares: after the market closes on December 10, the "Huatong convertible bonds" that have not been converted will stop converting shares; At present, there is only the last half trading day left before the "Huatong Convertible Bonds" stops converting shares, that is, the trading time on the afternoon of December 10th. The company specially reminded the holders of "Huatong Convertible Bonds" to complete the share conversion within the time limit. The "Huatong Convertible Bonds" that have not been converted after the closing of the market on December 10 will be forcibly redeemed at the price of 101.21 yuan/piece. ② Platinum New Materials: Recently, the company has completed the relevant filing and registration of production base projects in Thailand, and has successively received the Certificate of Overseas Investment of Enterprises issued by Shenzhen Municipal Bureau of Commerce and the Notice of Filing Overseas Investment Projects issued by Shenzhen Development and Reform Commission. ③ Baiao Intelligent: The company originally planned to absorb and merge its wholly-owned subsidiaries Kunshan Baisente Materials and Materials Co., Ltd. ("Baisente") and Kunshan Baiao Smart Logistics Co., Ltd. ("Smart Logistics"). Considering the company's actual operation and business development plan, the company plans to cancel the absorption and merger of Besant and Smart Logistics.The interest rates of 10-year treasury bonds and CDB active bonds all went down by about 5bp, while those of 24 interest-bearing treasury bonds went down by 4.9bp to 1.856%, and those of 24 CDB dropped by 5.25bp to 1.9175%.

Afternoon comment: The Shanghai Composite Index rose more than 1% in half a day, and consumer concept stocks broke out collectively. The index was active in early trading. The Shanghai Composite Index rose more than 1% in half a day, and the Shanghai Composite Index rose more than 2%. In terms of sectors, robot concept stocks continued to break out, and the concept of PEEK materials led the rise. Both China Research Institute and Xinyi New Materials had a daily limit of 20cm, while Zhongxin Fluorescent Materials and Walter shares touched the daily limit; The large consumer sector collectively rose, with dairy stocks leading the gains, and Panda Dairy, Western Animal Husbandry and Li Ziyuan were trading daily; AI concept stocks fluctuated higher, and it is worth buying 20cm daily limit, Hanwang Technology, Xinhua Media and other daily limit; Insurance stocks strengthened, and Tianli Technology, Astar, Focus Technology and other daily limit. Overall, individual stocks showed a general upward trend, with more than 4,600 stocks rising. On the disk, all sectors in the two cities generally rose, with PEEK materials, film and television theaters and dairy sectors among the top gainers.Brussels investigates the secret advertising transactions between Google and Meta for teenagers, and Brussels investigates the secret advertising transactions between Google and Meta for teenagers. European regulators asked Google to provide more information about its cooperation with Meta secret advertising.The Shanghai and Shenzhen 300 Index opened at 4042.28 points in the afternoon, up 1.91%. The Shanghai Composite Index opened at 3,456.49 points in the afternoon, up 1.59%. Shenzhen Component Index opened at 10,958.68 points in the afternoon, up 2.12%. The GEM index opened at 2,299.14 points in the afternoon, up 2.25%. Small and medium-sized board opened at 11,786.93 points in the afternoon, up 1.99%.

Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.This round of Palestinian-Israeli conflict has killed 44,758 people in the Gaza. According to a statement issued by the health department in Gaza on December 10th, local time, since the new round of Palestinian-Israeli conflict broke out on October 7th last year, Israeli military operations in Gaza have killed 44,758 Palestinians and injured 106,134 others.Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.